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ResearchK+ channel openers restore verapamil-inhibited 
lung fluid resolution and transepithelial ion 
transport
Dong-Yun Han†1, Hong-Guang Nie†1,4, Xiu Gu1,5, Ramesh C Nayak1, Xue-Feng Su1, Jian Fu1, Yongchang Chang3, 
Vijay Rao1 and Hong-Long Ji*1,2
Abstract
Background: Lung epithelial Na+ channels (ENaC) are regulated by cell Ca2+ signal, which may contribute to calcium 
antagonist-induced noncardiogenic lung edema. Although K+ channel modulators regulate ENaC activity in normal 
lungs, the therapeutical relevance and the underlying mechanisms have not been completely explored. We 
hypothesized that K+ channel openers may restore calcium channel blocker-inhibited alveolar fluid clearance (AFC) by 
up-regulating both apical and basolateral ion transport.
Methods: Verapamil-induced depression of heterologously expressed human αβγ ENaC in Xenopus oocytes, apical and 
basolateral ion transport in monolayers of human lung epithelial cells (H441), and in vivo alveolar fluid clearance were 
measured, respectively, using the two-electrode voltage clamp, Ussing chamber, and BSA protein assays. Ca2+ signal in 
H441 cells was analyzed using Fluo 4AM.
Results: The rate of in vivo AFC was reduced significantly (40.6 ± 6.3% of control, P < 0.05, n = 12) in mice intratracheally 
administrated verapamil. KCa3.1 (1-EBIO) and KATP (minoxidil) channel openers significantly recovered AFC. In addition to 
short-circuit current (Isc) in intact H441 monolayers, both apical and basolateral Isc levels were reduced by verapamil in 
permeabilized monolayers. Moreover, verapamil significantly altered Ca2+ signal evoked by ionomycin in H441 cells. 
Depletion of cytosolic Ca2+ in αβγ ENaC-expressing oocytes completely abolished verapamil-induced inhibition. 
Intriguingly, KV (pyrithione-Na), K Ca3.1 (1-EBIO), and KATP (minoxidil) channel openers almost completely restored the 
verapamil-induced decrease in Isc levels by diversely up-regulating apical and basolateral Na+ and K+ transport 
pathways.
Conclusions: Our observations demonstrate that K+ channel openers are capable of rescuing reduced vectorial Na+ 
transport across lung epithelial cells with impaired Ca2+ signal.
Background
Drug-induced noncardiogenic lung edema is one of the
pulmonary manifestations of the life-threatening side
effects resulting from an overdose of medicines. All four
subgroups of calcium channel blockers (CCB) have been
reported to lead to both cardiogenic and noncardiogenic
pulmonary edema [1-8]. CCB-induced noncardiogenic
edema appears to be due to diffuse damage and increased
permeability of the alveolocapillary membrane, which
results in accumulation of excess fluid in alveolar air
spaces [9]. To keep the alveolar space free from flooding,
accumulated cytosolic salts are extruded [10-12]. The
major determinant pathway for this process is apically
located epithelial Na+ channels (ENaC). Increasing
amounts of etiological evidence suggests that genetic and
pathologic ENaC deficiency gives rise to the genesis of
flooding airspaces [13,14]. For example, α ENaC knock-
out leads to the death of newborn mice due to their
inability to resolve amniotic fluid in their lungs [15]. In
adult lungs, high attitude pulmonary edema and patho-
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gen-challenged edematous lung injuries have been linked
to a reduction of both ENaC expression and activity levels
[16,17].
Basolateral K+ channels in epithelia play a major role in
maintaining the electrochemical gradient necessary for
Na+ and Cl- transepithelial transport, and in restoring the
resting membrane potential. The potential physiological
importance of voltage-gated K+ channels (KV), calcium-
activated K+ channels (KCa), and ATP-sensitive K+ chan-
nels (KATP) in transepithelial ion transport has been
implicated [18-22]. KV channels constitute a large family
(i.e., KVLQT1-KV7.1, KNCQ, and KCNQ channels). So
far, KCNQ 3 and 5 but not 1 have been identified in H441
cells by a very recent publication [23]. KCa channels, until
recently known as K Ca3.1 and BKCa, are functionally
detected in ENaC-expressing primary airway and ATII
cells [24-26]. These commonly basolaterally located K
Ca3.1 channels are blocked by clotrimazole and are acti-
vated by 1-ethyl-2-benzimidazolinone (1-EBIO). KATP
channels, which can be inhibited by glibenclamide and
activated by minoxidil, have been identified in both fetal
and adult alveolar cells [21,27]. These three types of K+
channels have been confirmed to functionally modify the
ionic and fluid transepithelial transport in cystic fibrosis
airway epithelial cells [22] and may have an important
role in lung fluid clearance [21,28]. These crucial K+
channels together with basolaterally located Na+/K+-
ATPase recycle K+ ions across interstitial membrane of
alveolar cells. The regulation of transepithelial Na+ trans-
port by the K+ channel blockers in normal primary alveo-
lar type II cells has recently been reported [21,25]. The
underlying mechanisms for the coupling of Na+ and K+
transport are unknown. More importantly, K+ channel
openers facilitated alveolar fluid clearance in resected
human lungs [29] and transepithelial ion transport in
human airway [30]. However, whether K+ channel open-
ers are able to restore the CCB-inhibited transepithelial
salt and fluid clearance in edematous lungs remains to be
elucidated.
Verapamil has been broadly used clinically for combat-
ing hypertension, ischemic heart diseases, supraventricu-
lar tachyarrhythmias, and tycolysis. In this study, we
investigated the effects of verapamil on ENaC activity in
confluent H441 monolayers-a human bronchoalveolar
epithelial cell line, in Xenopus oocytes heterologously
expressing human αβγ ENaC, and in murine lungs. Our
results showed that K+ channel openers recovered vera-
pamil-inhibited vectorial Na+ transport in H441 cells.
Moreover, verapamil-reduced alveolar fluid resolution
can be restored by these K+ channel openers in murine
lungs.
Methods
Cell culture
NCI-H441 (H441) cells were obtained from the American
Type Culture Collection (ATCC). H441 cells were grown
in RPMI medium (ATCC) containing 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 10 mM HEPES, 1 mM
sodium pyruvate, 4.5 g/L glucose, 1.5 g/L sodium bicar-
bonate and antibiotics (100 U/ml penicillin and 100 μg/
ml streptomycin). Dexamethasone (250 nM, Sigma) was
supplemented to stimulate ENaC expression. Cells were
seeded on permeable support filters (Costar) at a supra-
confluent density (~5 × 106 cells/cm2), and incubated in a
humidified atmosphere of 5% CO2-95% O2 at 37°C. Cells
reached confluency in the Costar Snapwell culture cups
24 hrs after plating. At this point media and non-adher-
ent cells in the apical compartment were removed to
adapt the cells to air-liquid interface culture. Culture
media in the basolateral compartment was replaced every
other day; whereas the apical surface was rinsed with
PBS. An epithelial tissue voltohmmeter (World Precision
Instruments) was used to monitor the transepithelial
resistance. Highly polarized tight monolayers with resis-
tance >800 Ω·cm2 were selected for Ussing chamber
assays.
In vivo alveolar fluid clearance
Animals were kept under pathogen-free conditions, and
all procedures performed were approved by the Institu-
tional Animal Care and Use Committee of the University
of Texas Health Science Center at Tyler. Alveolar fluid
clearance was examined in vivo as previously described
by us and other groups [31-34]. Briefly, 8-10 week old,
weighting 20-30 g, pathogen-free, male C57/BL/6 mice
were used (National Cancer Institute). An isosmotic
instillate containing 5% bovine serum albumin (BSA) was
prepared with 0.9% NaCl. Anesthetized mice were venti-
lated with 100% O2 via a volume-controlled ventilator
(model 683, Harvard Apparatus) for a 30-minute period.
5% BSA (0.3 ml), with or without verapamil (100 μM) and
amiloride (1 mM) was instilled intratracheally. The
instilled alveolar fluid was aspirated by applying gentle
suction to the tracheal catheter with a 1-ml syringe. The
BSA content of the alveolar fluid was measured with a 96-
well microplate reader. Alveolar fluid clearance (AFC)
was calculated as follows: AFC = (Vi - Vf)/Vi*100, where
Vi and Vf denote the volume of the instilled and recov-
ered alveolar fluid, respectively. Vf was obtained as Vf =
(Vi * Pi )/Pf, where Pi and Pf represent protein concentra-
tion of instilled and collected fluid.
Ussing chamber assays
Measurements of short-circuit current (Isc) in H441
monolayers were performed as described previously [35].
Briefly, H441 monolayers were mounted in vertical
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Ussing chambers (Physiologic Instruments) and bathed
on both sides with solutions containing (in mM) 120
NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.83 K2HPO4, 1.2 CaCl2,
1.2 MgCl2, 10 HEPES, 10 mannitol (apical compartment)
and 10 glucose (basolateral compartment). Each solution
was iso-osmolalic (approximately 300 mmol/Kg), as mea-
sured by a freezing depression osmometer (Wescor). The
transepithelial Isc levels were measured with 3 M KCl, 4%
agar bridges placed 3 mm on either side of the mem-
brane, which were connected on either side to Ag-AgCl
electrodes. The filters were bathed on both sides with the
above salt solution as designed, bubbled continuously
with a 95% O2-5% CO2 gas mixture (pH 7.4). The temper-
ature of the bath solution (37°C) was maintained using a
water bath. The transmonolayer potential was short-
circuited to 0 mV, and Isc level was measured with an epi-
thelial voltage clamp (VCC-MC8, Physiologic Instru-
ments). A 10-mV pulse of 1s duration was imposed every
10s to monitor Rt. Data were collected using the Acquire
and Analyse program (version 2.3; Physiologic Instru-
ments). When Isc level reached plateau, drugs were
pipetted to the either apical or basolateral compartment.
To determine whether verapamil decreases the
amiloride-sensitive Isc level across the apical membrane,
100 μM amphotericin B, a pore-forming antibiotic
(Sigma), was added to the basolateral side of Ussing
chamber to permeabilize the basolateral membrane [36].
A 145:25 mM Na+ ionic gradient (apical to basolateral
compartment) was established by replacing 120 mM Na+
ions with equal molar N-methyl-D-glucamine, an imper-
meant cation in the basolateral bath solution. Basolateral
permeabilization equilibrates intracellular Na+ concen-
tration to 25 mM in the basolateral bath. To exclude any
potentially residual Na+/K+-ATPase activity, 1 mM oua-
bain was added to the interstitial compartment. Under
these experimental conditions, amiloride-sensitive Isc
level reflects passive electrogenic Na+ movement through
ENaC down the Na+ concentration gradient [37,38].
When Isc level had attained its stable level, verapamil was
applied to the apical side and amiloride-sensitive current
component was determined by adding 100 μM amiloride.
To examine the ouabain-inhibitable Isc level across the
basolateral membrane, the apical membrane was perme-
abilized with 10 μM amphotericin B. Apical permeabili-
zation loads the cytosol with Na+ ions thereby eliciting
the maximal active Na+ transport by the Na+/K+-ATPase
[39]. To eliminate any remaining ENaC activity, 100 μM
amiloride was included in the apical bath. Under these
experimental conditions, ouabain-inhibitable basolateral
Isc shall associate with Na+/K+-ATPase, tightly coupling
with K+ channels. When the Isc level was stable, vera-
pamil and K+ channel modulators were applied. To deter-
mine Na+/K+-ATPase activity, 1 mM ouabain was added
to the basolateral compartment at the end of recording.
Oocyte preparation and voltage clamp analysis
Oocytes were surgically removed from appropriately
anesthetized adult female Xenopus laevis (Xenopus
Express) and cRNAs for human α, β, and γ ENaC were
prepared as described previously [40]. Briefly, the ovarian
tissue was removed from frogs under anesthesia by ethyl
3-aminobenzoate methanesulfonate salt (Sigma) through
a small incision in the lower abdomen. Follicle cells were
removed and digested in OR-2 Ca2+-free medium (in
mM: 82.5 NaCl, 2.5 KCl, 1.0 MgCl2, 1.0 Na2HPO4, and
10.0 HEPES, pH 7.5) with the addition of 2 mg/ml colla-
genase (Roche Indianapolis). Defolliculated oocytes were
cytosolically injected with ENaC cRNAs (25 ng) per
oocyte in 50 nl of RNase free water and incubated in half-
strength L-15 medium at 18°C for 48 h. Oocytes were
impaled with two electrodes filled with 3 M KCl, having
resistances of 0.5-2 MΩ. A TEV-200 voltage clamp ampli-
fier (Dagan) was used to clamp oocytes with concomitant
recording of currents. The continuously perfused bathing
solution was ND96 medium (in mM: 96.0 NaCl, 1.0
MgCl2, 1.8 CaCl2, 2.5 KCl, and 5.0 HEPES, pH 7.5). To
prepare a Ca2+-free bath solution, CaCl2 was omitted and
5 mM EGTA was added. To chelate intracellular Ca2+
ions, 10 μM BAPTA_AM was added to the Ca2+-free bath
solution. Experiments were controlled by pCLAMP 10.1
software (Molecular Devices), and currents at -40, -100,
and +80 mV were continuously monitored with an inter-
val of 10 s. Data were sampled at the rate of 1,000 Hz and
filtered at 500 Hz.
Fluo 4 AM measurements
Intracellular Ca2+ signal elicited by ionomycin in epithe-
lial cells was measured as described previously [41-44].
H441 cells were grown on chambered coverglass for 48 h.
Culture medium was aspirated and cells were loaded with
cell permeable Fluo 4 AM dye (4 μM, Invitrogen, CA) for
1 h. The Fluo 4 AM loaded cells were then incubated with
verapamil or culture medium for 10 min. The cells were
placed on the specimen stage of an inverted microscope
(AxioObserver Z1, Carl Zeiss) equipped with a LSM 510
Meta confocal system (Carl Zeiss, Germany). The argon
ion 488 nm laser line was used to excite Fluo 4 AM fluo-
rochrome and the serial live cell images for the emission
signal of Fluo 4 AM were captured for a period of 6 min
40 s at an interval of 4 s using a 20 ×/0.8 Plan-apochro-
mate objective lens. Subsequent to a 2 min image acquisi-
tion, 15 nM ionomycin was added into the chamber to
evoke an increment in cytosolic Ca2+ signal. In all cases, a
confluent field of cells was chosen for imaging. The rela-
tive Ca2+ signal was measured as the ratio of fluorescent
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intensity (F/F0) using ZEN 2007 Zeiss imaging software
and plotted as a function of recording time.
Statistics
Electrophysiological data from Ussing chamber and volt-
age-clamp studies were primarily analyzed with the
Acquire and Analyze 2.3 (Physiologic Instruments) and
Clampfit 10.1 (Molecular Devices), respectively. The
measurements were then imported into OriginPro 8.0
(OriginLab) for statistical computation and graphic plot.
The IC50 and EC50 values of verapamil and K+ channel
openers were calculated by fitting the dose-response
curves with the Hill equation.
All results are presented as mean ± S.E.M. The
unsorted data were examined for the normal distribution
using either the Kolmogorov-Smirnov normality test with
specified parameters previously published or Lilliefors
test. Those without significantly drawn from the nor-
mally distributed population were selected for t-test and
ANOVA analyses. For the comparison of mean values of
repeated measures of short-circuit and whole-cell activi-
ties, paired two-tailed Student t-test was used. For
unpaired electrophysiological data, one-way ANOVA
analysis combined with a post hoc Tukey-Kramer test
was used. For analyses of in vivo alveolar fluid clearance,
mean values between control and CCB challenged groups
were compared by the unpaired two-sample Student t-
test for both equal variance assumed or not. The mean
and SE values of amiloride-sensitive AFC fraction were
computed using the following equations:
and
where Mt and Ma are mean values of total and
amiloride-resistant fractions; tc is the t.95 value of a free-
dom of (nt+na-2) in the t-table; SEt and SEa are SE values
of total and amiloride-resistant AFC. M, SE, and n stand
for mean, standard error, and number of mice, respec-
tively. For nonparametric data (i.e., Ca2+ signal), the
Mann-Whitney U-test was used. The power of sample
size was simultaneously evaluated to assure the actual
power value > 0.95. P < 0.05 was considered statistically
significant.
Results
Verapamil reduces murine in vivo fluid resolution
To examine the potential deleterious effects of calcium
channel blockers (CCB) on fluid resolution in distal lung
air spaces, we measured in vivo alveolar fluid clearance
(AFC) in anesthetized C57/B6 mice. As plasma verapamil
predominately affects cardiovascular function, which
may lead to both cardiogenic and noncardiogenic pulmo-
nary edema as reported clinically [1-8], we intratracheally
delivered verapamil into lung to avoid any dysfunction
beyond air spaces. As shown in Fig. 1A, the normal AFC
rate was 23.6 ± 1.3% (n = 15). Intratracheal instillation of
verapamil (100 μM) markedly reduced the re-absorption
of the 5% BSA instillate (11.4 ± 1.2%, P < 0.05, n = 12),
which was almost identical to that in the presence of
amiloride (1 mM, 12.1 ± 0.8%, n = 4, P < 0.05 vs Control).
In the presence of both amiloride and verapamil, fluid
resolution was 10.6 ± 0.9% (P < 0.01 vs Control, n = 4),
suggesting that verapamil almost completely inhibited
amiloride-sensitive fraction of AFC (Fig. 1B). These in
vivo data clearly demonstrate that CCB impairs transalve-
olar fluid clearance, which in turn results in fluid accu-
mulation in lung sacs.
K+ channel openers profoundly restore verapamil-inhibited 
alveolar fluid clearance
K+ channel openers activated transepithelial ion trans-
port in alveolar monolayers in vitro under physiological
conditions [25]. It prompted us to hypothesize that K+
channel openers may be capable of recovering the vera-
pamil-inhibited fluid resolution in vivo. To address this
promising pharmaceutical issue, three types of K+ chan-
nel openers, namely, pyrithione-Na (1 mM for KV), 1-
EBIO (1 mM for K Ca3.1), and minoxidil (0.6 mM for KATP)
were intratracheally delivered in the presence (Fig. 1D)
and absence of verapamil (Fig. 1C). The K+ openers
slightly but not significantly altered AFC (Fig. 1C). In
sharp contrast, depressed AFC (10.4 ± 1.3%) in the pres-
ence of verapamil was pronouncedly relieved by 1-EBIO
(17.6 ± 2.5%, n = 4, P < 0.05) and minoxidil (17.3 ± 2.3%, n
= 4, P < 0.05). These data suggest that augmentation of K+
efflux from lung epithelial cytosol facilitates salt/fluid re-
absorption in verapamil-injured edematous lungs.
Calcium antagonists abrogate transepithelial short-circuit 
current (Isc) in intact H441 monolayers
Human bronchoalveolar epithelium-derived Clara cells
(H441) have been used extensively to study lung epithelial
Na+ channels, in which ENaC properties are similar to
those in primary alveolar type II cells [45-48]. To examine
the effects of verapamil on the electrogenic transepithe-
lial Na+ transport in lung epithelial cells, confluent H441
monolayers were mounted in an 8-chamber Ussing
chamber system. Verapamil inhibited Isc levels when
applied to the luminal side of H441 monolayers in a dose-
dependent manner (Fig. 2A). The IC50 value was 294.2
μM calculated by fitting the dose-response curve with the
Hill equation (Fig. 2B). Nevertheless, verapamil did not
M M t SE
nt na
t a c− ± ⋅ ⋅ +
1 1
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nt SEt na SEa
nt na
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affect the Isc levels in amiloride-exposed monolayers
(Fig. 2C &2D, before 2.1 ± 0.6 μA/cm2 and after verapamil
2.0 ± 0.2 μA/cm2, P>0.05, n = 3). These results suggest
that verapamil inhibits vectorial transepithelial ion trans-
port in a dose-dependent manner in intact monolayers.
To measure the regulation of ENaC-associated transep-
ithelial Isc levels by representative examples from the
other three subgroups of CCB compounds, confluent
H441 monolayers were exposed to nifedipine, bepridil,
and diltiazem (Fig. 3). As shown by the representative
current traces, a reduction in the Isc levels was recorded
following bolus addition of nifedipine (200 μM), bepridil
(10 μM), or diltiazem (50 μM) (Fig. 3A-C). To compare
the inhibitory efficacy of these four subgroups of CCB
compounds, verapamil (100 μM) was applied subse-
quently to these CCB compounds. Interestingly, vera-
pamil resulted in a further decrease in the Isc levels. On
average, nifedipine, bepridil, and diltiazem inhibited
amiloride-sensitive (AS) Isc levels by 29.8 ± 4.4% (P <
0.01, n = 4), 31.6 ± 6.6% (P < 0.01, n = 3), and 11.7 ± 1.3%
(P < 0.01, n = 3), respectively (Fig. 3D). Subsequent addi-
tion of verapamil to each group showed a further reduc-
tion in the Isc levels to approximately the same level of
70% of total reduction (Fig. 3). Because verapamil dis-
played potent inhibition on the AS Isc levels in H441
cells, this drug was then used for the follow-up experi-
ments.
Figure 1 Recovery of verapamil-reduced alveolar fluid clearance (AFC) by K+ channel openers in vivo. (A) Verapamil intratracheal application 
reduces alveolar fluid clearance. Verapamil (100 μM) was intratracheally delivered to mouse lung. Average AFC values in the absence of drugs (Con-
trol), in the presence of amiloride (Amiloride), verapamil (Verapamil), and both (Amiloride+Verapamil). Unpaired two-sample two-tailed Student t-test. 
*P < 0.05 and **P < 0.01 when compared with Control. n = 4-15. (B) Amiloride-sensitive (AS) AFC. The mean and SE values were computed as described 
in Methods. Unpaired two-sample two-tailed Student t-test. **P < 0.01. n = 12-15. (C) Effects of K+ channel openers on basal AFC. Unpaired two-sample 
two-tailed Student t-test. n = 5-15. (D) K+ channel openers restore verapamil-reduced AFC. AFC values were measured for Verapamil (100 μM) alone, 
+ Pyrithione-Na (1 mM), + 1-EBIO (1 mM), and +Minoxidil (0.6 mM). The dashed line indicates the Control level. Unpaired two-sample two-tailed Stu-
dent t-test. *P < 0.05 vs Verapamil alone. n = 4-12.
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Verapamil, as well as other CCB compounds, is cell per-
meable and therefore may cross the thin alveolocapillary
membrane and exhibit its inhibitory effects in the alveo-
lar space. To investigate whether or not verapamil has the
same effects on the Isc levels when applied to the basolat-
eral and apical sides, we performed a set of experiments
by adding verapamil (100 μM) to either basolateral or api-
cal compartment (Fig. 4). AS Isc levels were inhibited by
both basolateral and apical addition of verapamil by 41.4
± 2.6% and 38.8 ± 1.7%, respectively (Fig. 4D, n = 4-17).
However, addition of the same volume of water did not
alter Isc level (Fig. 4A). These data suggest that verapamil
reduces AS Na+ channels to a similar extent regardless of
its application to either luminal or interstitial compart-
ment.
Verapamil inhibits both apical and basolateral Na+ 
conductance in permeabilized H441 monolayers
It has been reported that the total Na+ Isc level in polar-
ized lung epithelial monolayers is predominately deter-
mined by apical and basolateral vectorial Na+ movement
[13]. We asked whether verapamil might regulate electro-
genic pathways across both apical and basolateral mem-
brane. To examine the effects of verapamil on apical Na+
influx, amphotericin B (100 μM) was applied to permea-
bilize the basolateral membrane (Fig. 5A). A large Na+ ion
gradient was applied to the permeabilized H441 mono-
layer to facilitate passive Na+ transport predominately
through ENaC channels. To confidentially eliminate all of
Na+/K+-ATPase enzymatic activity, ouabain (1 mM) was
added to the basolateral compartment. Permeabilization
of the basolateral membrane caused a reduction in the Isc
Figure 2 Verapamil reduces short-circuit (Isc) level in H441 monolayers in a dose-dependent manner. (A) Representative Isc trace showing 
applications of a series of concentrations. Amiloride-sensitive Isc level (AS Ibasalsc) is the sum of verapamil-inhibitable and residual amiloride-sensitive 
fractions. (B) Normalized AS Isc levels (AS Iverasc/AS Ibasalsc) at each concentration were plotted as a dose-response curve. n = 6. The raw data were fitted 
with the Hill equation. IC50 value, 294.2 μM. (C) & (D) Verapamil on amiloride-insensitive Isc levels in amiloride pretreated cells. Representative trace 
(C) and corresponding average Isc levels before (Control) and after addition of amiloride and verapamil (D). n = 3. P = 0.89 for the Isc levels before and 
after verapamil. Paired t-test.
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level, suggesting that a relatively larger Na+ gradient
across apical membrane exists in intact cells (apical
145:~10 mM in cytosol) than basolateral permeabilized
monoalyers (145:25 mM). Verapamil inhibited transapi-
cal AS Isc levels from 9.5 ± 0.9 to 6.7 ± 0.8 μA/cm2 (paired
t-test, P < 0.001, n = 8, Fig. 5B). Clearly, verapamil regu-
lates AS apical Na+ conductance in the absence of cytoso-
lic soluble signal elements.
We then examined the effects of verapamil on Na+/K+-
ATPase in apically permeabilized confluent H441 mono-
layers with amphotericin B (10 μM). To eliminate possi-
bility of any AS apical Na+ channels still remaining in the
apically permeabilized cells, amiloride (100 μM) was
added to the apical compartment. As shown in Fig. 5C, in
the presence of amiloride, apical permeabilization caused
a dramatic increase in the Isc level, a hallmark of evoked
Na+/K+-ATPase activity following an increment in "cyto-
solic" Na+ ions. Verapamil resulted in a marked drop of
the ouabain-sensitive (OS) Isc level from 6.0 ± 1.3 to 3.7 ±
1.1 μA/cm2 (P < 0.05, n = 4, Fig. 5D). These experiments
provide direct evidence that verapamil inhibits Na+/K+-
ATPase in the apically permeabilized H441 cells.
Verapamil serves as a K+ channel blocker
Verapamil has been known to alter cytosolic Ca2+ con-
centration and to modify a number of K+ channels [49].
We hence speculated that verapamil might indirectly
influence ENaC activity by altering K+ channels. The
basolateral K+ channels tightly regulate Na+/K+-ATPase
activity, by coordinately acting as the K+ recycling
machinery to maintain the negative resting membrane
potential. Resultant depolarization of polarized epithelial
cells, a consequence of impaired K+ recycling, weakens
the electrochemical driving force for ENaC activity. We
thereby attempted to determine the individual contribu-
tion of each functional subtype of K+ channels (KV, KCa3.1
Figure 3 Effects of CCB compounds on transepithelial short-circuit currents (Isc) in intact H441 monolayers. (A-C) Typical traces. 200 μM nife-
dipine (A), 10 μM bepridil (B) or 50 μM diltiazem (C) was added to the basolateral compartment followed by verapamil. Amiloride (100 μM, apical side) 
was finally applied to inhibit residual amiloride-sensitive currents. Arrows show the time point of addition. Total AS Isc is the difference between the 
Isc level before CCB and the amiloride-insensitive fraction, as indicated by a pair of vertical arrows. (D) CCB-sensitive fraction: CCB-inhibitable Isc/total 
AS Isc. One-way ANOVA. *P < 0.05 vs Verapamil. n = 3-10.
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and KATP) to verapamil-inhibited ENaC activity. The rep-
resentative Isc traces showed the verapamil-induced
decrease in AS Isc subsequent to addition of 100 μM clo-
filium, 5 μM tram34, and 100 μM glibenclamide, respec-
tively (Fig. 6A). These concentrations were supposed to
completely block corresponding K+ channels as described
previously [21,25]. As summarized in Fig. 6B, clofilium,
tram34, and glibenclamide decreased the AS Isc levels by
54.4 ± 4.6% (P < 0.05, n = 4), 19.1 ± 1.8% (P < 0.001, n = 7),
20.5 ± 1.1% (P < 0.01, n = 4), respectively. Subsequent
addition of verapamil resulted in a further reduction of
the residual AS Isc levels by 23.7 ± 4.3%, 40.3 ± 1.6%, and
36.0 ± 2.8%, respectively. Blockade of KCNQ (3 and 5)
[23] but not KCa3.1 and KATP channels significantly
affected the response of AS Na+ channels to verapamil
(Fig. 6C, P < 0.05), when compared to the control (38.8 ±
1.7%, n = 17). Our results showed that these three sub-
types of K+ channels are functionally expressed in H441
cells at a various levels, in accordance with other studies
[21,25]. Moreover, inhibition of these K+ channels by the
related specific blockers can influence the inhibitory
effects of verapamil on AS Na+ channels to various
extents.
K+ channel openers restore verapamil-inhibited Isc levels in 
intact H441 cells
Our in vivo studies suggest K+ channel openers may alter
ENaC-like activity. To address this issue, K+ channel
openers were added basolaterally subsequent to vera-
pamil (100 μM) as shown in Fig. 7A. A set of increasing
concentrations for pyrithione-Na (KV7.1 opener at 5 μM
and KCNQ at larger concentrations), 1-EBIO (K Ca3.1
opener), and minoxidil (KATP opener) were applied to the
basolateral compartment. The average concentration-
response curves were plotted in Fig. 7B. The half-maxi-
mal effective concentrations (EC50) were 2.4 μM, 391.8
μM, and 1.2 μM, respectively, for pyrithione-Na, 1-EBIO,
and minoxidil. To maximally activate these K+ channels,
Figure 4 Comparison of verapamil-inhibitable Isc levels in H441 monolayers when applied to the apical or basolateral compartments. (A-
C) Representative Isc traces showing the effects of water (H2O), verapamil applied to basolateral (B) and apical (C) compartments. The total AS Isc 
levels associated with ENaC are designated by pairs of vertical arrows. (D) AS Isc levels before and after verapamil delivery to the basolateral side or 
apical compartment. Paired t-test for comparison of current levels before and after verapamil. *P < 0.05 and **P < 0.01. n = 4-17.
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the concentration used for each type of K+ channels was
based on the results of the dose-response studies (Fig. 7A
&7B). As shown in Fig. 7C, pyrithione-Na (10 μM), 1-
EBIO (600 μM), and minoxidil (10 μM) significantly
increased AS Isc levels from 14.9 ± 1.7 to 17.8 ± 2.4 μA/
cm2 (P < 0.01, n = 6), 12.9 ± 1.9 to 18.6 ± 2.6 μA/cm2 (P <
0.01, n = 6), and 14.9 ± 2.4 to 19.4 ± 2.8 μA/cm2 (P < 0.05,
n = 3), respectively. These encouraging observations
imply that stimulating K+ secretion with K+ channel
openers can reverse, at least partially, verapamil-inhibited
AS transepithelial Na+ pathways. In fact, this set of exper-
iments was initiated with a low dose of pyrithione-Zn
(ZnPy, 10 μM), which was supposed to specifically open
heterologously expressed KVLQT1 current, one of large
KV family [50]. Interestingly, only a transient increment
was observed followed by a continuing decline in an hour
(Additional file 1). This is likely due to the non-specific
effects of Zn2+ ions on transepithelial ion transport sys-
tems, including ENaC [51-54]. We thus had to utilize its
sodium compound, which has a divergent EC50 value for
native KV channels in H441 cells (Fig. 7B).
We also tried to prevent the inhibitory effects of vera-
pamil on the AS Isc levels by addition of K+ channel
openers prior to verapamil. The similar transient or sus-
tained elevation in the Isc levels was observed following
the application of the K+ channel openers but inexplicably
the subsequent application of verapamil inhibited Isc lev-
els to the same extent as that of control monolayers in the
absence of K+ channel openers (data not shown). In sharp
contrast to the significant recovery effects of verapamil-
inhibited ion transport, the K+ channel openers did not
prevent the verapamil-induced depression in transepithe-
lial ion transport. These observations indicate that
instead of keeping K+ channels from the inhibitory of
verapamil, K+ channel openers are only able to recover
impaired K+ channel activities.
Diverse stimulating effects of K+ channel openers on apical 
and basolateral ion transport
Recovery of verapamil-inhibited transepithelial Isc levels
in H441 cells (Fig. 7) by the K+ channel openers raised a
new question of what Na+ transport systems are regulated
by the K+ channel openers, apical ENaC or basolateral
Figure 5 Inhibition of transapical and transbasolateral Isc levels by verapamil in permeabilized H441 monolayers. (A) Representative Isc trac-
es obtained in basolateral permeabilized H441 monolayers with amphotericin B (am B). 1 mM ouabain was added to the basolateral side to exclude 
any potential residual Isc across basolateral membrane. Amiloride (100 μM) was applied at the end of recording to calculate basal amiloride-sensitive 
(AS) Isc level as indicated between dashed lines. (B) AS Isc levels before (Basal) and after water (H2O) and verapamil (Verapamil). Paired t-test. ***P < 
0.001. n = 4-8. (C) Representative Isc trace recorded in apically permeabilized H441 monolayers with amphotericin B. 100 μM amiloride was added to 
the apical compartment to inhibit possible residual Isc level carried by ENaC. Ouabain (1 mM) was added at the end of the recording to calculate total 
ouabain-sensitive (OS) Isc level. (D) Mean OS Isc levels in the absence (Basal) and presence of water (H2O) and verapamil (Verapamil). Paired t-test. *P 
< 0.05. n = 4.
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Figure 6 K+ channel blockers alter the inhibitory effects of verapamil in H441 cells. (A) Typical Isc traces showing the application of 100 μM vera-
pamil alone (control), 100 μM clofilium (KV inhibitor), 20 μM tram34 (KCa3.1 inhibitor), and 100 μM glibenclamide (KATP inhibitor), respectively. These K+ 
channel blockers were applied to basolateral side followed by verapamil and amiloride (apical side) to compute total AS Isc. (B) Summary of average 
AS Isc levels. Paired t-test. *P < 0.05, **P < 0.01, *** P < 0.001 for comparison of pre- and post exposure of CCB. n = 4-17. (C) Reduced percentages of 
AS Isc levels by verapamil in H441 cells with and without pretreatment of K+ channel blockers. Two-sample, two-tailed t-test. *P < 0.05 vs Control. n = 
4-17.
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Na+/K+-ATPase. To address this question, K+ channel
openers were applied to either apical or basolateral mem-
brane permeabilized monolayers. In basolateral permea-
bilized cells, neither KCNQ (pyrithione-Na) nor KATP
(minoxidil) channel openers altered AS transapical Na+
influx (Fig. 8A &8C). However, KCa3.1 channel opener (1-
EBIO) approximately restored half (49.1 ± 22.3%) of the
depressed AS Isc level. Regarding transbasolateral ion
transport, pyrithione-Na and 1-EBIO but not minoxidil
(64.6 ± 9.2%) completely restored the verapamil-inhibited
OS Isc levels in apical membrane permeabilized H441
monolayers (Fig. 8B &8D). Taken together, these results
suggest that KCa3.1 channels are probably located at both
apical and basolateral membranes in H441 cells, while
pyrithione- and minoxidil-activated channels may be
expressed at the basolateral membrane only.
Direct regulation of αβγ ENaC by verapamil in X. laevis 
oocytes
To address the question of whether verapamil directly
regulate human ENaC, human α, β, and γ ENaC subunits
were co-expressed in X. laevis oocytes, and the effects of
verapamil on heterologously expressed ENaC were
assessed. Verapamil inhibited ENaC current in an oocyte
under physiological conditions (Fig. 9A), which is consis-
tent with the results in H441 cells. An average of 38.2 ±
5.5% ENaC currents was reduced by verapamil (P < 0.05,
n = 4, Fig. 9C), suggesting that verapamil may also
directly reduce native ENaC channel activity in H441
cells.
If intracellular Ca2+ signal mediates the down-regula-
tion of αβγ ENaC by verapamil, one may expects that cell
permeable Ca2+ chelator could have the same effect. To
address this issue, BAPTA_AM was superfused on
oocytes bathed in the Ca2+-free solution. In an oocyte
perfused with the Ca2+-free bath solution (5 mM EGTA,
0 mM Ca2+), the whole-cell ENaC current declined grad-
ually (Fig. 9B). The residual ENaC currents were no lon-
ger sensitive to verapamil under these Ca2+-depletion
conditions (the ENaC current even increased by 0.4 ±
1.5% after correction of the run-down slope, P>0.05 com-
pared with basal current, n = 4, Fig. 9D). Obviously, vera-
Figure 7 Stimulatory effects of K+ channel openers subsequent to verapamil in H441 monolayers. (A) Representative traces showing response 
to a set of K+ channel openers from 1 μM to 1 mM in the presence of verapamil. (B) Corresponding concentration-response curves. The raw data were 
fitted with the Hill equation and the EC50 were 2.4, 391.8, and 1.2 μM, respectively, for pyrithione-Na, 1-EBIO, and minoxidil. (C) Summary of AS Isc levels 
before (Basal) and after verapamil (Verapamil) and K+ channel openers (10 μM Pyrithione-Na, 600 μM 1-EBIO, 10 μM Minoxidil). Paired t-test. *P < 0.05, 
**P < 0.01 for comparison of before and after K+ channel openers. n = 3-6.
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pamil down-regulates human αβγ ENaC in a cytosolic
Ca2+- dependent fashion in oocytes. We also tried to
repeat these experiments in Ca2+ depleted H441 mono-
layers, unfortunately, the resistance and current levels
post BAPTA_AM exposure were too low to detect due to
impaired gap junctions and ion transport (data not
shown).
Verapamil alters cytosolic Ca2+ signal
The regulation of alveolar ENaC by Ca2+ signal has been
documented by the well-designed in vivo and in vitro
studies [55,56]. We reason that verapamil may interfere
with transepithelial Na+ transport by altering cell Ca2+
signal, which is regulated by mechanic stress associated
with breath. The intracellular Ca2+ signal was measured
with Fluo 4AM in real time using confocal microscopy
(Additional files 1 &2) in H441 cells in the absence or
presence of verapamil. Ionomycin was added to the
chamber to mimic the Ca2+ wave caused by breath. An
approximately three-fold increment in fluorescent inten-
sity was observed following the exposure to ionomycin
(Fig. 10A &10B, Additional file 2). In comparison, this
increment was significantly diminished in the presence of
verapamil (Fig. 10A &10B, Additional file 3). In addition,
Figure 8 Compartment-dependent recovery of verapamil-inhibited Isc levels by K+ channel openers in permeabilized H441 monolayers. 
(A) Representative Isc traces of apical Isc level in the presence of 1 mM ouabain in the basolateral membrane permeabilized monolayers. (B) Repre-
sentative Isc traces of basolateral Isc level in the presence of 100 mM amiloride in the apical permeabilized H441 monolayers. (C & D) Recovered apical 
(C) and basolateral (D) Isc levels by K+ channel openers. One-way ANOVA for comparing normalized Isc level post K+ channel openers with total AS or 
OS Isc levels. *P < 0.05 and **P < 0.01. n = 3-5.
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the time required to reach the maximal value of fluores-
cent intensity was considerably prolonged in verapamil
exposed cells (Fig. 10C, P < 0.05).
Discussion
We aimed to study the cellular mechanistic pathogenesis
of the CCB-induced noncardiogenic defect in lung fluid
clearance. Ussing chamber studies suggest that transepi-
thelial Na+ transport is inhibited by four structurally dis-
tinct subgroups of CCB compounds in human lung
epithelial cells (H441 cells). Verapamil reduces amiloride-
sensitive (AS) Isc levels in a concentration-dependent
manner. Ca2+ signal is involved in the down-regulation of
AS Na+ transport by verapamil. Furthermore, verapamil
alters K+ recycling via stimulating the apical and basolat-
eral K+ channels as well as Na+/K+-ATPase activity. K+
channel openers restore the suppressed ENaC activity in
vitro to a significant extent. Of note, our in vivo alveolar
fluid clearance (AFC) studies show that K+ channel open-
ers restore the verapamil-inhibited fluid resolution.
A Ca2+ signal has been shown to up-regulate alveolar
fluid clearance and epithelial Na+ channel activity [55,57].
Depletion of intracellular Ca2+ by thapsigargin in late-ges-
tational guinea pig lungs completely inhibited amiloride-
sensitive AFC [55]. On the other hand, elevation of intra-
epithelial Ca2+ concentration by β-adrenergic agonists
and other AFC-enhancing reagents, for example, terbuta-
line, has been confirmed [58]. CCB partially blocked
terbutaline-stimulated Na+ absorption via amiloride-sen-
sitive channels in primary rat alveolar type II cells [57,59].
Our results that show BAPTA_AM completely abolishes
verapamil-induced inhibition of αβγ ENaC activity in
oocytes suggest that the regulation of ENaC by CCB is at
least partially mediated by an alteration in cytosolic Ca2+
Figure 9 Verapamil regulates heterologously expressed human αβγ ENaC in oocytes in a Ca2+-dependent pattern. (A & B) Time-courses of 
whole-cell current traces at -100 mV recorded in oocytes perfused with verapamil under normal (A) and Ca2+-chelated conditions (B). 10 μM amiloride 
were added at the end of recording to compute basal and verapamil-inhibitable ASI levels. (C & D) Effects of verapamil on ENaC activity in control (C) 
and Ca2+-chelated (D) oocytes. The shift of base line in Ca2+-chelated cells (B) was corrected for comparing the current levels before (Basal) and after 
verapamil (Verapamil). Paired t-test. *P < 0.05.
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signal (Fig. 10). The observation that verapamil inhibits
ionophore-induced Ca2+ mobilization supports this
notion. The direct inhibitory effects of Ca2+ ions on ENaC
in vitro [60,61] were, perhaps, overwhelmed by the stimu-
latory effects of Ca2+ downstream signals on ENaC and
other transporters in these cell models and in vivo stud-
ies.
Accumulating evidence demonstrates that the regula-
tion of epithelial K+ channels by the Ca2+ signal. The
expression of various K+ channels has been detected in
alveolar and bronchial epithelial cells [20]. Ca2+ signal
may regulate those K+ channels by both directly affecting
the gating kinetics and serving as a second messenger for
signal transduction. On the other hand, the relationship
between a Ca2+ signal and Na+/K+-ATPase is not known.
Control of endoplasmic reticulum (ER) Ca2+ release by
Na+/K+-ATPase has been recently confirmed in "knock-
out" cultured renal epithelial cells [62]. It raises the possi-
bility that CCB may directly inhibit Na+/K+-ATPase and
in turn alter the intracellular Ca2+ content. Nevertheless,
our data clearly confirm that impaired K+ ion transport
across alveolar basolateral membrane is an essential
mechanism for CCB to inhibit ENaC function. Interrup-
tion of K+ ion recycling may be a critical mechanism for
CCB-induced inhibition of ENaC activity (Fig. 11).
What are the underlying mechanisms for the diverse
regulation of apical and basolateral conductance by K+
channel openers? If the K+ channel openers restore the
depressed ENaC and Na+/K+-ATPase by stimulating K+
influx which facilitates Na+/K+-ATPase in intact cells, no
effects on ENaC should be observed in basolateral per-
meabilized monolayers. Intriguingly, K Ca3.1 channel
opener still activated ENaC. It is possible that KCa chan-
nels are expressed in apical membrane [29]. Increased
Figure 10 Verapamil inhibits ionophore-induced Ca2+ mobilization. Transient Ca2+ signal evoked by ionomycin was measured as relative fluores-
cent intensity with Fluo 4AM dye in real time with paired manner, in both control and verapamil incubated H441 cells. (A) Original traces showing on-
time Ca2+ signal digitized in control (red) and verapamil exposed cells (green). (B) Maximal relative change in fluorescent intensity (Fpeak/F0). Nonpara-
metric Mann-Whitney U-test. *P < 0.05 vs Control. n = 3. (C) The time to reach peak signal. Nonparametric Mann-Whitney U-test. *P < 0.05
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extrusion of K+ ions in the presence of 1-EBIO may
locally build up an electrical gradient resulting in elevated
ENaC activity. Another possibility is that 1-EBIO directly
stimulates ENaC. The less effect of minoxidil in permea-
bilized monolayers, by comparison to the results in intact
H441 cells, in vivo fluid clearance, and previous publica-
tion [29], may be due to loss of cell ATP.
CCB compounds may not act on the same Ca2+ entry/
exit pathways due to their divergent pharmaceutical
properties [63]. Lung epithelial Ca2+ content is deter-
mined by Ca2+ influx/efflux pathways, endoplasmic retic-
ulum (ER) Ca2+ release, and concentration of Ca2+-
binding proteins. Ca2+ ions may enter epithelia through,
for example, L-type Ca2+ channels, ECaC, and other TRP
channels; while Ca2+-ATPase and Ca2+/Na+ exchanger are
major transporters to extrude Ca2+ ions. Our results indi-
cate that verapamil may not alter basal Ca2+ content,
instead, the Ca2+ wave, possibly due to Ca2+ release from
cytosolic compartments, was abolished (Fig. 11).
The potent efficacy of K+ channel openers to recover
transepithelial Na+ reabsorption and fluid clearance may
be a promising therapeutic approach to mitigate drug-
induced as well as other deleterious agents-induced non-
cardiogenic lung edema. On the other hand, inhalation
CCB compounds will definitely bring life-threatening
noncardiogenic lung edema to patients. Reasonably, any
medicines capable of depleting lung epithelial Ca2+ ions
may have the same fatal side-effect when delivered either
intravenously or intratracheally. Indeed, nifedipine can-
not prevent lung edema in mountain sickness [64].
As supported by our observations in permeabilized
H441 monolayers and Ca2+-depleted cells, verapamil
inhibited basolateral and apical K+ conductance directly.
Verapamil inhibits IK (KCa3.1) channels with an IC50 value
of 72 μM, various KV channel subtypes between 10-200
μM and KATP channels at ~10 μM [65-67]. Moreover, con-
centrations typically used to achieve nearly complete
inhibition of voltage-gated Ca2+ channels is less than 100
μM. Therefore, it is most likely that verapamil alters
ENaC activity via multiple mechanisms, for example,
through Ca2+-mediated regulation, direct inhibition of
ENaC, and interrupting K+ recycling (Fig. 11). In sum-
mary, CCB reagents decrease vectorial transepithelial
Na+ transport directly by inhibiting apical ENaC and indi-
rectly by altering cytosolic Ca2+ signal and K+ recycling at
the basolateral membrane. Recovery of the CCB-
depressed edema resolution by K+ channel openers indi-
cates that pharmaceutical augmentation of K+ recycling
may be a potent strategy to combat CCB-induced non-
cardiogenic lung edema.
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blocker for heterologously expressed KV channels, pyrithione zinc tran-
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level is approximately 0 for AS Isc fraction.
Additional file 2 Video clip in a control H441 cell. Fluo 4AM fluorescent 
intensity was monitored in real time before and after addition of ionomycin.
Additional file 3 Video clip in a verapamil incubated H441 cell. Fluo 
4AM fluorescent intensity was monitored in real time before and after addi-
tion of ionomycin.
Figure 11 Schematic model for the multiple mechanisms of CCB-
inhibited transepithelial Na+ transport and recovery by K+ chan-
nels. CCB compounds alter Ca2+ signal most likely via modifying Ca2+ 
release from cytosolic compartments. In addition, CCB compounds di-
rectly regulate K+ channels, ENaC, and Na+/K+-ATPase. Disrupted baso-
lateral K+ recycling and apical ion transport will abrogate transalveolar 
salt and fluid transport. K+ channel openers significantly restore the 
CCB-inhibited transepithelial Na+ transport by activating K+ channel, 
then facilitating Na+/K+-ATPase.
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